Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya

March 12, 2009 updated by: Academy for Educational Development

Randomized Controlled Evaluation of the Impact of Food Supplements on Malnourished HIV-Infected Adult ART Clients and Malnourished, HIV-Infected Pre-ART Adults in Kenya

The purpose of the study is to test whether food supplementation of malnourished HIV-infected adults (both pre-ART and ART) in resource constrained settings improves their nutritional status, clinical status, effectiveness of treatment, quality of life, functioning, and survival.

Study Overview

Detailed Description

Malnutrition remains a significant problem among HIV-infected populations, even among those with access to ART. In patients with HIV infection, poor nutritional status is associated with significant reduction in survival rates, accelerated disease progression, diminished response to therapies including ART, increased susceptibility to opportunistic infections, and reduced work capacity and quality of life. However, there is not evidence whether delay or reversal of weight loss improves life expectancy, nor is there evidence about the specific benefits food supplementation has on people with HIV infection. As antiretroviral therapy (ART) services continue to scale up in sub-Saharan Africa, there is a critical need for information about the impacts of appropriate food supplementation on the effectiveness of ART, on the health status of clients, and on the progression of the disease.

Malnourished adult ART and pre-ART clients at six clinical sites in Kenya are randomly allocated either to a group that receives nutrition counseling only or a group that receives nutrition counseling and supplementary feeding for six months. All patients continue to receive medical treatment (ART and other medicine) according to their condition. Baseline measures of socioeconomic and demographic status are collected. Measures of both nutritional and non-nutritional clinical outcomes are collected at baseline, 3, 6, 9, and 12 months. Clients beginning ART are treated as one arm and randomized between food and non-food, and clients not yet eligible for ART (pre-ART) are treated as a second arm and randomized between food and non-food. Within each arm, outcomes of subjects receiving supplemental food will be compared with outcomes of those who are not.

Study Type

Interventional

Enrollment (Actual)

1049

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Maragwa, Kenya
        • Maragwa District Hospital
      • Nairobi, Kenya
        • Mbagathi District Hospital
      • Nairobi, Kenya
        • Mathere North Hospital
      • Nairobi, Kenya
        • Riruta City Council Hospital
      • Naivasha, Kenya
        • Naivasha District Hospital
      • Nyeri, Kenya
        • Nyeri Provincial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • HIV-infected
  • BMI < 18.5
  • Resident of area for past 6 months

Exclusion Criteria:

  • Pregnant or lactating (child < 6 months)
  • BMI > 18.5, BMI < 14
  • Already receiving other food supplements

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ART: food
ART + food supplementation + nutrition counseling
300 grams/day for 6 months
Other Names:
  • Insta Products Ltd. Foundation Plus product with whey protein concentrate.
Active Comparator: ART: no food
ART + nutrition counseling
Active Comparator: pre-ART: food
no ART (cotrimoxazole provided) + food supplementation + nutrition counseling
300 grams/day for 6 months
Other Names:
  • Insta Products Ltd. Foundation Plus product with whey protein concentrate.
Active Comparator: pre-ART: no food
no ART (cotrimoxazole provided) + nutrition counseling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Body Mass Index
Time Frame: monthly
monthly

Secondary Outcome Measures

Outcome Measure
Time Frame
CD4 counts
Time Frame: every three months (quarterly)
every three months (quarterly)
Quality of Life
Time Frame: monthly
monthly
drug adherence
Time Frame: monthly
monthly

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James Muttunga, Ph.D., Kenya Medical Research Institute
  • Principal Investigator: Robert Mwadime, Ph.D., Academy for Educational Development, FANTA Project

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2006

Primary Completion (Actual)

June 1, 2008

Study Completion (Actual)

June 1, 2008

Study Registration Dates

First Submitted

February 3, 2009

First Submitted That Met QC Criteria

February 5, 2009

First Posted (Estimate)

February 6, 2009

Study Record Updates

Last Update Posted (Estimate)

March 13, 2009

Last Update Submitted That Met QC Criteria

March 12, 2009

Last Verified

February 1, 2009

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AED 1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV Infections

3
Subscribe